Wednesday, February 27, 2013

Upcoming Webinar: Impact of New 2013 HIPAA Omnibus Rules on Law Firms (CLE Eligible)

Our next webinar features a panel comprising speakers from Hunton & Williams, Carlson & Wolf and IntApp and will review recent HIPAA rule updates that create new requirements and challenges for law firms.

The 2013 HIPAA Omnibus Rule has raised the stakes for any law firm that provides services to the healthcare industry. Under the new regulations, law firms that interact with protected health information (PHI) are directly liable for compliance with the entire HIPAA Security Rule and select provisions of the Privacy Rule, including the requirement that uses and disclosures of PHI must be limited to the “minimum necessary” to accomplish an intended purpose.
Our speakers will review how key rule changes affect law firms and how law firms can best respond. Topics will include:
  • Analysis of key regulation changes that impact law firms
  • Explanation of HIPAA Security Rule requirements
  • Overview of breach notification requirements
  • Assessment of penalties for non-compliance
  • Overview of technologies available to remediate compliance gaps
  • Best practices for information security
We're pleased to feature several speakers, including Lisa Sotto from Hunton & Williams, who has been rated as the #1 privacy expert for three consecutive years by Computerworld magazine.

Date: Wednesday, March 13
Time: 9 am Pacific / 12 pm Eastern
Duration: 75 minutes

CLE CREDIT: As a certified as a CLE approved educator by the State Bar of California, we are able to provide California certificates to attendees upon request. (Attendees are responsible for confirming CLE reciprocity in their particular jurisdiction. We are happy to provide additional information required to receive credit outside of California, bttendees are responsible for researching and identifying information for their local jurisdictions and filing any necessary paperwork.)

Attendance is by invitation only. For more information, please contact:

No comments:

Post a Comment